NEWS, INSIGHTS AND ANALYSIS ABOUT Innovation in health

The current panorama of rare diseases and the prospects for the future, according to geneticist Ciro Martinho and Antoine Daher, president of Casa Hunter, Casa dos Rares and Febrararas

What to expect from the psychedelic market in 2024? A brief overview with insights from the CEO of Scirama Psychedelic Science and the CEO of Clínica Beneva helps us to think about the future

Other diseases are in the spotlight, the difference between techbio and biotech, difficulties in raising funds and what should change in the biotechnology market in the coming year

Learn more about the evolution of precision medicine, the challenges, possibilities, and investments in Brazil and the world.

In 2022, the country had a total of 153,831 patients on dialysis, marking a growth of 57.6% over the last decade and a notable increase of 182.1% in the period from 2003 to 2022

With the pandemic, awareness has increased about the importance of daily choices for a longer and healthier life, stimulating the vitamin market, which has a great potential to be explored in Brazil.

In the field of health in the silver economy, a latent demand is related to the mental and cognitive health of the elderly population, who are often neglected and isolated from society

Alexandre Chiavegatto navigates the universe of artificial intelligence in health, answering the biggest current questions on the topic

The area of dentistry has undergone a period of appreciation and is one of the targets of attention and interest in health care in Brazil and in the world.

In the midst of a market with a large supply of professionals, complaints about dental plans and a supplementary system concentrated on major players, W. Dental is differentiated by its focus on experience.

Eduardo Medeiros tells how healthtech Welbe emerged and consolidated in the occupational health market in Mexico.

The pandemic boosted health innovation in Latin America, which has been led by healthtechs, especially Brazil and Mexico.

In an interview, Olivier Capoulade and Morgan Autret, founders of Omens, comment on the male sexual health scene in Brazil.

In an interview, Marina Ratton and Marília Ponte, from Feel, share their perception about femtechs and the women's sexual health market.

In an interview, Ubiraci Mercês, founder and CEO of Sanar, recounts the company's trajectory and ponders medical education in Brazil.

Alexandre Santini, CEO of the Altana Network, discusses dehospitalization in Brazil and the world, addressing the model of transition hospitals and home care.

Medical education in Brazil faces challenges that range from the lack of residence vacancies to the emergence of ChatGPT.

Dehospitalization has been seen as a possible trend in health, but there is still a lot of space in the Brazilian market, both for home care services and for transition hospitals.

Denis Cruz, CEO of SimCo, who is in the middle of the market for popular clinics, shares his vision on this scenario.

In short, popular clinics emerge from a gap left by the SUS and operators, expanding access to health in Brazil.

The current health model, marked by fee for service, is experiencing a crisis. The possibility of a value-based model is questioned.

In an interview, Cesar Abicalaffe discusses the current health scenario and the challenges of the value-based healthcare model.

Fernando Soares, CEO of CM Tecnologia, assesses the potential of data integration in health and the main market challenges.

Interoperability is one of the most discussed guidelines in the health sector today, in the public and private spheres, with the expectation of contributing to a more efficient system. But what does that mean?

Exclusively, CEO of HRTech Closecare ponders the context of fraud in medical certificates and talks about the gap that the company saw.

Health fraud is still a somewhat invisible topic, but it causes losses that impact the entire chain of supplementary health.

The supplementary health system faces difficulties at the tip of operators experiencing losses, service providers who are slow to receive, and clients who suffer from readjustments. Is there a way out?

Population aging is a reality and has implications for the health system and the market. In response, there is the growth of the silver economy, which generated US$ 300 billion worldwide in 2019.

Lukas Fischer, CEO of Endogen, ponders the main challenges of the Brazilian medical cannabis market and believes that there will be a prevalence of the model proposed by RDC No. 327, which allows it to be marketed in pharmacies.

Despite obstacles closely related to the stigma of recreational use, the medical cannabis market is growing in Brazil and around the world, especially for the treatment of refractory conditions.